Ardelyx: Is There Any Value Left After The Unexpected CRL?
Bet_Noire/iStock via Getty Images
Ardelyx (NASDAQ:ARDX) was handed a CRL on July 29. The CRL wasn’t unexpected in July; after the FDA’s July 13 letter flagging deficiencies in the tenapanor NDA, the CRL was almost a certainty. However, before that, nobody…
